Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$177.82
-4.73-2.59%
al cierre: Nov 25, 4:00 PM EST
$176.89
-0.93-0.52%
After hour: 7:59 PM EST
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
NVIDIA Corp tiene un precio objetivo de consenso de $254.5 basado en las calificaciones de 36 analistas. El máximo es $352, emitido por Evercore ISI Group el noviembre 20, 2025. El mínimo es $165, emitido por Raymond James el mayo 29, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Citigroup, Barclays y JP Morgan el noviembre 20, 2025, respectivamente. Con un precio objetivo promedio de $265 entre Citigroup, Barclays y JP Morgan, hay una 49.81% upside implícita para NVIDIA Corp según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Citigroup
Barclays
JP Morgan
Jefferies
Oppenheimer
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para NVIDIA
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/20/2025 | 52.64% | Citigroup | $220 → $270 | Maintains | Buy | |||
11/20/2025 | 55.46% | Barclays | $240 → $275 | Maintains | Overweight | |||
11/20/2025 | 41.33% | JP Morgan | $215 → $250 | Maintains | Overweight | |||
11/20/2025 | 41.33% | Jefferies | $240 → $250 | Maintains | Buy | |||
11/20/2025 | 49.81% | Oppenheimer | $265 → $265 | Reiterates | Outperform → Outperform | |||
11/20/2025 | 98.99% | Evercore ISI Group | $261 → $352 | Maintains | Outperform | |||
11/20/2025 | 41.33% | Susquehanna | $230 → $250 | Maintains | Positive | |||
11/20/2025 | 44.16% | Truist Securities | $228 → $255 | Maintains | Buy | |||
11/20/2025 | 38.5% | Mizuho | $235 → $245 | Maintains | Outperform | |||
11/20/2025 | 32.85% | Morgan Stanley | $220 → $235 | Maintains | Overweight | |||
11/20/2025 | 24.37% | Argus Research | $220 → $220 | Reiterates | Buy → Buy | |||
11/20/2025 | 55.46% | Baird | $225 → $275 | Maintains | Outperform | |||
11/20/2025 | 41.33% | DA Davidson | $250 → $250 | Maintains | Buy | |||
11/20/2025 | 30.02% | Wedbush | $210 → $230 | Maintains | Outperform | |||
11/20/2025 | 69.6% | Cantor Fitzgerald | $300 → $300 | Reiterates | Overweight → Overweight | |||
11/20/2025 | 38.5% | Rosenblatt | $240 → $245 | Maintains | Buy | |||
11/20/2025 | 55.46% | Keybanc | $250 → $275 | Maintains | Overweight | |||
11/20/2025 | 80.9% | Melius Research | $300 → $320 | Maintains | Buy | |||
11/20/2025 | 35.68% | Needham | $240 → $240 | Reiterates | Buy → Buy | |||
11/20/2025 | 41.33% | Benchmark | $220 → $250 | Maintains | Buy | |||
11/20/2025 | 21.54% | Deutsche Bank | $180 → $215 | Maintains | Hold | |||
11/20/2025 | 55.46% | Bernstein | $225 → $275 | Maintains | Outperform | |||
11/18/2025 | 41.33% | Stifel | $212 → $250 | Maintains | Buy | |||
11/14/2025 | 49.81% | Wells Fargo | $220 → $265 | Maintains | Overweight | |||
11/14/2025 | 41.33% | Keybanc | $250 → $250 | Reiterates | Overweight → Overweight | |||
11/14/2025 | 24.37% | Morgan Stanley | $210 → $220 | Maintains | Overweight | |||
11/13/2025 | 30.02% | Susquehanna | $210 → $230 | Maintains | Positive | |||
11/13/2025 | 49.81% | Oppenheimer | $225 → $265 | Maintains | Outperform | |||
11/10/2025 | 24.37% | Citigroup | $210 → $220 | Maintains | Buy | |||
11/03/2025 | 35.68% | Goldman Sachs | $210 → $240 | Maintains | Buy | |||
11/03/2025 | 35.68% | Rosenblatt | $215 → $240 | Maintains | Buy | |||
11/03/2025 | 97.86% | Loop Capital | $250 → $350 | Maintains | Buy | |||
10/29/2025 | 41.33% | DA Davidson | $210 → $250 | Maintains | Buy | |||
10/29/2025 | 32.85% | UBS | $205 → $235 | Maintains | Buy | |||
10/29/2025 | 69.6% | Cantor Fitzgerald | $300 → $300 | Reiterates | Overweight → Overweight | |||
10/29/2025 | 55.46% | B of A Securities | $235 → $275 | Maintains | Buy | |||
10/15/2025 | 80.9% | HSBC | $200 → $320 | Upgrade | Hold → Buy | |||
10/13/2025 | 27.2% | Mizuho | $205 → $225 | Maintains | Outperform | |||
10/09/2025 | 69.6% | Cantor Fitzgerald | $240 → $300 | Maintains | Overweight | |||
10/03/2025 | 35.68% | Cantor Fitzgerald | $240 → $240 | Reiterates | Overweight → Overweight | |||
09/30/2025 | 41.33% | Keybanc | $230 → $250 | Maintains | Overweight | |||
09/30/2025 | 18.72% | Citigroup | $200 → $210 | Maintains | Buy | |||
09/29/2025 | 24.37% | Jefferies | — | $205 → $220 | Maintains | Buy | ||
09/25/2025 | 35.68% | Barclays | $200 → $240 | Maintains | Overweight | |||
09/23/2025 | 18.72% | DA Davidson | $210 → $210 | Maintains | Buy | |||
09/23/2025 | 27.2% | Evercore ISI Group | $214 → $225 | Maintains | Outperform | |||
09/23/2025 | 21.54% | Rosenblatt | $215 → $215 | Maintains | Buy | |||
09/11/2025 | 18.72% | DA Davidson | $195 → $210 | Upgrade | Neutral → Buy | |||
09/08/2025 | 13.06% | Citigroup | $210 → $200 | Maintains | Buy | |||
09/04/2025 | 21.54% | JP Morgan | $215 → $215 | Maintains | Overweight | |||
08/28/2025 | 18.72% | Citigroup | $190 → $210 | Maintains | Buy | |||
08/28/2025 | 21.54% | JP Morgan | $170 → $215 | Maintains | Overweight | |||
08/28/2025 | 10.24% | DA Davidson | $135 → $195 | Maintains | Neutral | |||
08/28/2025 | 13.06% | Goldman Sachs | $200 → $200 | Reiterates | Buy → Buy | |||
08/28/2025 | 38.5% | Craig-Hallum | $195 → $245 | Maintains | Buy | |||
08/28/2025 | 27.2% | Oppenheimer | $200 → $225 | Maintains | Outperform | |||
08/28/2025 | 18.72% | Morgan Stanley | $206 → $210 | Maintains | Overweight | |||
08/28/2025 | 32.85% | B of A Securities | $220 → $235 | Maintains | Buy | |||
08/28/2025 | 18.72% | Wedbush | $210 → $210 | Reiterates | Outperform → Outperform | |||
08/28/2025 | 28.89% | Truist Securities | $210 → $228 | Maintains | Buy | |||
08/28/2025 | 35.68% | Cantor Fitzgerald | $240 → $240 | Reiterates | Overweight → Overweight | |||
08/28/2025 | 30.02% | Keybanc | $215 → $230 | Maintains | Overweight | |||
08/28/2025 | 27.2% | Bernstein | $185 → $225 | Maintains | Outperform | |||
08/28/2025 | 21.54% | Rosenblatt | $200 → $215 | Maintains | Buy | |||
08/28/2025 | 24.37% | Benchmark | $190 → $220 | Maintains | Buy | |||
08/28/2025 | 13.06% | Needham | $200 → $200 | Reiterates | Buy → Buy | |||
08/25/2025 | 19.85% | Stifel | $202 → $212 | Maintains | Buy | |||
08/25/2025 | 27.2% | Baird | $195 → $225 | Maintains | Outperform | |||
08/22/2025 | 20.98% | Evercore ISI Group | $190 → $214 | Maintains | Outperform | |||
08/21/2025 | 15.89% | UBS | $175 → $205 | Maintains | Buy | |||
08/21/2025 | 18.72% | Wedbush | $175 → $210 | Maintains | Outperform | |||
08/20/2025 | 21.54% | Keybanc | $190 → $215 | Maintains | Overweight | |||
08/19/2025 | 32.85% | TD Cowen | $140 → $235 | Maintains | Buy | |||
08/18/2025 | 35.68% | Cantor Fitzgerald | $200 → $240 | Maintains | Overweight | |||
08/18/2025 | 16.46% | Morgan Stanley | $200 → $206 | Maintains | Overweight | |||
08/14/2025 | 15.89% | Mizuho | $192 → $205 | Maintains | Outperform | |||
08/13/2025 | 27.2% | Piper Sandler | $180 → $225 | Maintains | Overweight | |||
08/11/2025 | 24.37% | Wells Fargo | $185 → $220 | Maintains | Overweight | |||
08/07/2025 | 13.06% | Goldman Sachs | $185 → $200 | Maintains | Buy | |||
08/04/2025 | 24.37% | B of A Securities | $220 → $220 | Reiterates | Buy → Buy | |||
07/30/2025 | 13.06% | Morgan Stanley | $170 → $200 | Maintains | Overweight | |||
07/16/2025 | 8.54% | Mizuho | $185 → $192 | Maintains | Outperform | |||
07/16/2025 | 13.06% | Needham | $160 → $200 | Maintains | Buy | |||
07/15/2025 | 24.37% | B of A Securities | $180 → $220 | Maintains | Buy | |||
07/15/2025 | 10.24% | DZ Bank | $160 → $195 | Maintains | Buy | |||
07/15/2025 | 32.85% | Melius Research | $205 → $235 | Maintains | Buy | |||
07/15/2025 | 13.06% | Oppenheimer | $175 → $200 | Maintains | Outperform | |||
07/10/2025 | 4.58% | Goldman Sachs | → $185 | Initiates | → Buy | |||
07/07/2025 | 7.41% | Citigroup | $180 → $190 | Maintains | Buy | |||
07/03/2025 | 4.58% | Mizuho | $170 → $185 | Maintains | Outperform | |||
06/25/2025 | 41.33% | Loop Capital | $175 → $250 | Maintains | Buy | |||
06/17/2025 | 13.06% | Barclays | $170 → $200 | Maintains | Overweight | |||
06/16/2025 | -1.07% | Oppenheimer | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/29/2025 | 1.76% | B of A Securities | $160 → $180 | Maintains | Buy | |||
05/29/2025 | 18.72% | Truist Securities | $205 → $210 | Maintains | Buy | |||
05/29/2025 | -6.72% | Raymond James | $150 → $165 | Maintains | Strong Buy | |||
05/29/2025 | 1.76% | Piper Sandler | $150 → $180 | Maintains | Overweight | |||
05/29/2025 | -3.9% | Mizuho | $168 → $170 | Maintains | Outperform | |||
05/29/2025 | 1.76% | Citigroup | $150 → $180 | Maintains | Buy | |||
05/29/2025 | -3.9% | Morgan Stanley | $160 → $170 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de NVIDIA (NVDA)?
El último precio objetivo de NVIDIA (NASDAQ:NVDA) fue comunicado por Citigroup el noviembre 20, 2025. La firma de analistas fijó un precio objetivo para $270.00 que espera NVDA a rise dentro de 12 meses (un posible 52.64% upside). 100 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre NVIDIA (NVDA)?
La última calificación de analistas para NVIDIA (NASDAQ:NVDA) fue proporcionada por Citigroup, y NVIDIA mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de NVIDIA (NVDA)?
La última revisión al alza de NVIDIA Corp se produjo en octubre 15, 2025, cuando HSBC elevó su precio objetivo a $320. HSBC anteriormente tenía a hold para NVIDIA Corp.
¿Cuándo fue la última revisión a la baja de NVIDIA (NVDA)?
No hay una última revisión a la baja para NVIDIA.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para NVIDIA (NVDA)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de NVIDIA, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de NVIDIA se registró el noviembre 20, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 20, 2026.
¿Es correcta la calificación de los analistas sobre NVIDIA (NVDA)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de NVIDIA (NVDA) fue un mantuvo con un precio objetivo de $220.00 a $270.00. El precio actual al que cotiza NVIDIA (NVDA) es de $176.89, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.